In terms of OS analysis, high expression levels of CEACAM5, MAD2L1, and PLK1 and downregulated expression of LAMB3, PYCARD, and TP63 were strongly linked to poor prognosis in BC patients, further supporting the selection of ARGs. This evidence concerns the gene CEACAM5 and breast cancer.